APA (7th ed.) Citation

Amaral, T., Chatziioannou, E., Nuebling, A., Sinnberg, T., Niessner, H., Leiter, U., . . . Forchhammer, S. Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: Head and neck subgroup analysis. Elsevier.

Chicago Style (17th ed.) Citation

Amaral, T., et al. Identification of Patients at High Risk for Relapse by Merlin Assay (CP-GEP) in an Independent Cohort of Patients with Melanoma Who Did Not Undergo Sentinel Lymph Node Biopsy: Head and Neck Subgroup Analysis. Elsevier.

MLA (9th ed.) Citation

Amaral, T., et al. Identification of Patients at High Risk for Relapse by Merlin Assay (CP-GEP) in an Independent Cohort of Patients with Melanoma Who Did Not Undergo Sentinel Lymph Node Biopsy: Head and Neck Subgroup Analysis. Elsevier.